Patients with chronic airways obstruction may experience improvement following the abandonment of smoking and treatment of infection, reversible airways obstruction or congestive cardiac failure. Compression of the airways by a solitary bullus may be treated surgically. Airways obstruction secondary to diffuse destructive emphysema has in the past been treated in a number of ways, including application of an abdominal binder (emphysema belt), induction of pneumoperitoneum, excision of the cartilages of the first ribs, lobectomy, excision and plication of parts of the lung or lung transplantation. At the present time partial resection offers the best prospect but this is effective for only a small proportion of patients (Abbott et al., 1953; Pride et al., 1970) and reversion is common in those with generalised disease. Shrinkage of the lung may also be achieved by the fibrosis which follows radiotherapy. We observed this in a patient with advanced emphysema who was treated by x-ray therapy for an oat-cell carcinoma; he subsequently had a reduction in breathlessness. This prompted us to investigate the effects of irradiation on 10 patients with established emphysema whose breathlessness had not responded to other treatment. The findings over the first two years after irradiation are described in this paper; a preliminary account, including a summary of discussion, is contained in the proceedings of the Association of Physicians ).
Subjects and methods
The patients all had incapacitating breathlessness with a grossly reduced ventilatory capacity (mean FEV,.o 044 1, range 02-0{75 1) and unequivocal clinical, radiographic, and physiological evidence for destructive emphysema including flat diaphragms, increased transradiancy, an enlarged thoracic gas volume, reduced lung recoil pressure, and high compliance. The transfer factor per unit of lung volume (Kco) was greatly reduced, there was moderate hypoxaemia, and the arterial carbon dioxide tension was at the lower end of the normal range.
Three patients (LW, WJF, and HP) had previously been referred for pulmonary resection but this was considered unadvisable on account of either the extent of the disease or the associated disability. The majority of the patients had little chest infection, not much response to bronchodilators, and no history of congestive cardiac failure, but several suffered from reactive depression secondary to hypoxaemia. Three patients 35 (OE, RJS, and JM) had experienced episodes of myocardial infarction; one (HTW) had category 1 simple pneumoconiosis of coalworkers. The emphysema was associated with smoking cigarettes (mean consumption 30/day) which all subjects had abandoned or, in two instances (OE and RSJ), reduced to a low level some time before the present treatment (range 6 months to 19 years). In one instance (WJF) there was additional local emphysema at the site of a previous lung abscess. The serum levels of ac-antitrypsin were within normal limits. Selection for treatment was made on clinical grounds including failure of conventional treatment and relentless progression of the disease to a stage where life was barely tolerable. The patient, his wife, and general practitioner shared in the decision.
A course of radiotherapy was given to each patient using a 4 million electron volt linear accelerator. Two opposed fields were used, one to the anterior chest and the other to the posterior chest, each of 10 by 10 cm at the skin surface, the focal skin distance being 100 cm. A total dose of 1600 rads was prescribed, assuming unit density of tissues; this dose was calculated at the centre of the irradiated volume. Treatment was given once weekly to each of the two fields for four weeks, that is, a weekly dose of 400 rads to the volume. Measurements of the exit doses were made using a method previously described (Svarcer et al., 1965) which enabled us to calculate the actual dose received by the centre of the lung irradiated.
This was on average about 30% higher than that obtained assuming unit density of tissues, the range being 1900 rads to 2300 rads with an average 2100 rads and was due to the reduced density of the lung. A second treatment of one or two doses each of 400 rads was given in some instances. The site for irradiation was selected where radioactive isotope studies using aggregated human albumin labelled with iodine-131 suggested that perfusion was absent or greatly reduced. In most instances the area selected exhibited increased transradiancy and/or bullae, but in one patient (ET) an area was selected which, while poorly perfused, had a relatively low transradiancy.
After the completion of radiotherapy the patients were seen for clinical consultation and, in most instances, for assessment of lung function at four-monthly intervals; however, the actual intervals varied and on several occasions the assessment was made after recovery from an acute chest illness. The measurements of lung function were performed by standard methods which are described elsewhere (Cotes, 1975) .
Results
Radiation was given to one upper zone in six instances and to a lower zone in four. It gave rise to symptoms in two subjects (DMJ and OE) who developed mild congestive cardiac failure within eight hours of their first period of irradiation. The failure responded well to conventional remedies and did not recur with subsequent treatment. One patient (WJF) developed symptoms of chest illness on returning from the first of a second course of treatment which was then terminated. Two patients (WJF and TWB) at the time of their third irradiation (that is, on the 15th day) commented that their chests did not feel so full and they could take a deeper breath.
Since the completion of treatment the patients have been followed for up to 31 years. During this time three patients have developed radiographic evidence of radiation fibrosis and four have died, in two instances (LW and OE) from cardiac arrest while in hospital under our care, one (RSJ) from a cerebrovascular accident and one (JM) from protracted chest infection. Three of these patients had a previous history of myocardial infarction. At necropsy in the case of LW where irradiation was given to the right lower zone, there was widespread centrilobular emphysema of both lower lobes but the right lower lobe was smaller and less distensible than the left and contained an increased amount of fibrous tissue. In the case of OE, where irradiation was given to the right upper zone, the right lung was grossly emphysematous with cystic changes in the upper lobe. The left upper lobe and apical segment of the left lower lobe were also largely destroyed by emphysema. In the case of JM, where irradiation was given to both upper zones there was extensive bilateral emphysema with little evidence of fibrosis. Immediately before treatment the distance which the subjects could walk was on average 75 m (range 4-400 m); only one subject (HTW) could mount a flight of stairs and all had their beds downstairs on this account; only one (ET) did not have difficulty in dressing and undressing; none could take a bath unaided; and four patients found conversation difficult and laughing impossible on account of breathlessness.
Subsequent to the treatment all the patients reported that at best they could walk a greater distance than before treatment, the average proportional increase being 550%. Six could mount a flight of stairs and four reverted to using an upstairs bedroom. Three of these men reported doing some home painting and paper hanging for the first time for several years. For all patients, washing, dressing, and conversation became less of a problem, and for three patients laughter was no longer impossible.The most dramatic improvements were experienced by WJF, who from having been confined to one room for three years could walk 45 m up the street to his daughter's house, and by ET, who was able to go to the Chepstow races and resume his part-time voluntary work as an instructor in occupational therapy. The average time interval from the start of treatment to the first recorded improvement was 13 weeks (range 2 weeks to 11 months). The experience of the 10 patients individually is summarised in the Appendix.
The measurements of lung function did not on average show any change during the first six months after treatment. Subsequently (Table) the Table Mean static lung compliance was significantly reduced and the recoil pressure of the lung at both total lung capacity and 20% vital capacity below total lung capacity were increased. There was on average no change in the body weight, ventilatory capacity, lung volumes, transfer factor or physiological response to submaximal exercise; in two patients (HP and ET) the maximal exercise ventilation was increased (Figure) .
Discussion
In patients with chronic airways obstruction, breathlessness is due primarily to a reduced ventilatory capacity. In emphysema, the airways become narrower or obstructed during expiration on The possibility that relief of asthma is responsible for our subjects' clinical improvement is small since none was diagnosed as having asthma and the average increase in forced expiratory volume after administration of bronchodilator drugs was only 11% (range 0-29%).
Chronic bronchitis was present in seven of the 1O patients; this was mainly in winter when almost all of them were confined to the house, but only in the case of JM was bronchitis the main clinical problem. Exacerbation of bronchitis may have delayed the onset of clinical improvement after therapy in the case of ET, and it undoubtedly contributed to the long-term deterioration of some of the other patients. However, our manner of treating chest infections did not change over the period of study, and the results before radiotherapy were obtained during periods of remission; thus the control of chest illnesses is unlikely to have contributed to the clinical improvement. Alternatively, the improvement might be due to the patients responding to the renewed interest and drama associated with the treatment. This seems to us improbable on account of both the slow onset of improvement which was first appreciated by the patients on average three months after the start of treatment and the length of time over which we have observed them both before and after radiotherapy. The question can be resolved only by a controlled trial.
The application of radiotherapy for a condition other than cancer requires justification on account of the treatment possibly hazarding the lung or other organs. The risks include leukaemia or other malignancy, destruction of bone marrow, fibrosis of the heart, radiation pneumonitis and fibrosis, respiratory failure or congestive cardiac failure, and reactivation of infection. However, review of the literature and our own experience suggest that in the dosage used the risks of radiotherapy are small in relation to the other hazards to which these patients are already exposed and wholly justifiable if the quality of life can be improved. It is our impression that the improvement is material and of useful duration but this has still to be confirmed by the double-blind controlled trial which is now in progress.
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